Loading clinical trials...
Loading clinical trials...
Correlation of Feasibility Batches Using Warfarinised Blood
The purpose of this study is to measure prothrombin time (PT) on an experimental device and a commercially available device on persons receiving coumadin (warfarin)treatment.
This study will require participants to have up to 2 finger-punctures taken and sample tested on a strip and meter system for both the experimental and commercially available devices.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
White River Diagnostic Clinic
Batesville, Arkansas, United States
Start Date
May 1, 2011
Primary Completion Date
November 1, 2011
Completion Date
November 1, 2011
Last Updated
May 9, 2011
200
ESTIMATED participants
Lead Sponsor
Universal Biosensors Pty Ltd
NCT00178594
NCT03734588
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions